MiNK Therapeutics, Inc. (INKT): Price and Financial Metrics

MiNK Therapeutics, Inc. (INKT): $0.70

0.02 (+2.61%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add INKT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#252 of 356

in industry

INKT Price/Volume Stats

Current price $0.70 52-week high $1.90
Prev. close $0.69 52-week low $0.57
Day low $0.67 Volume 21,900
Day high $0.71 Avg. volume 89,095
50-day MA $0.73 Dividend yield N/A
200-day MA $0.88 Market Cap 27.88M

INKT Stock Price Chart Interactive Chart >


MiNK Therapeutics, Inc. (INKT) Company Bio


MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate includes AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.


INKT Latest News Stream


Event/Time News Detail
Loading, please wait...

INKT Latest Social Stream


Loading social stream, please wait...

View Full INKT Social Stream

INKT Price Returns

1-mo -2.78%
3-mo -14.63%
6-mo -27.09%
1-year -33.33%
3-year -95.85%
5-year N/A
YTD -34.58%
2023 -59.00%
2022 -41.48%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!